Tomorrow Biostasis' Case report 2026 (for 2025 cases)

Emil Kendziorra, the co-founder and CEO of cryonics provider Tomorrow Biostasis, presents report on quality of Tomorrow Bio's cryopreservation cases done in 2025.

Some important highlights:

- why public quality reports matter
- the mindset about handling issues during cryopreservation
- quality of cases in USA in particular
- recalibration on CT scanes based on pig tests
- electron microscopy quality tests of vitrified brain tissue (more in a dedicated webinar)
- big change on 18th February 2026
- Q&A